Remdesivir is hard to obtain around the world

When a drug called Remdesivir showed promising signs in preliminary COVID-19 trials, the US allowed it to be used in hospitals. But around the globe, access to this new drug has been extremely difficult. In fact, it’s unclear whether huge parts of Latin America, especially, hit hard by COVID-19, will have a way to get it at all. The World’s Elana Gordon reports.